Paratek Pharmaceuticals to Present Data at ICAAC 2015
August 03, 2015 16:01 ET
|
Paratek Pharmaceuticals
BOSTON, Aug. 3, 2015 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon...
Paratek Pharmaceuticals to Report Second Quarter 2015 Financial Results on August 5, 2015
July 28, 2015 08:00 ET
|
Paratek Pharmaceuticals
BOSTON, July 28, 2015 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) today announced that it will host a conference call and live audio webcast on Wednesday, August 5, 2015, at 8:30...
Paratek Announces Termination of Tax Benefit Preservation Plan
July 24, 2015 16:05 ET
|
Paratek Pharmaceuticals
BOSTON, July 24, 2015 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon...
Timothy Franson M.D. Joins Paratek's Board of Directors
July 22, 2015 08:00 ET
|
Paratek Pharmaceuticals
BOSTON, July 22, 2015 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon...
Paratek Pharmaceuticals Opens New Corporate Headquarters in Boston
July 21, 2015 08:00 ET
|
Paratek Pharmaceuticals
BOSTON, July 21, 2015 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon...
Paratek Hires William Haskel as Senior Vice President, General Counsel and Corporate Secretary
July 01, 2015 08:00 ET
|
Paratek Pharmaceuticals
BOSTON, July 1, 2015 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon...
Paratek Doses First Patient in Phase 3 Clinical Trial of Omadacycline in Acute Bacterial Skin and Skin Structure Infections
June 23, 2015 09:07 ET
|
Paratek Pharmaceuticals
- First of Two Planned Phase 3 Clinical Trials of Paratek's Lead Antibiotic Candidate
- Studies Designed to Support Submission for Approval in Two Indications: Acute Bacterial Skin and Skin...
Paratek Set to Join Russell 3000(R) and Russell Global Indexes
June 22, 2015 08:00 ET
|
Paratek Pharmaceuticals
BOSTON, June 22, 2015 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon...
Paratek Pharmaceuticals to Present at Upcoming Banking Conferences
June 17, 2015 16:01 ET
|
Paratek Pharmaceuticals
BOSTON, June 17, 2015 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon...
Paratek Pharmaceuticals Opens Philadelphia Office
June 11, 2015 08:00 ET
|
Paratek Pharmaceuticals
KING OF PRUSSIA, Pa., June 11, 2015 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative...